Home › Funds › Holocene Advisors, LP › EW

Holocene Advisors, LP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Holocene Advisors, LP reported holding 3,139,285 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$284.0M, representing 0.67% of its reported portfolio and ranking #30 among its reported holdings. Holocene Advisors, LP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.14M sh
Reported value held$283.98M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Holocene Advisors, LP's EW position evolved

Holocene Advisors, LP first disclosed a stake in EW in Q3 2023 at 625,078 shares (US$43.3M). The position peaked in Q3 2025 at 4,746,694 shares, worth US$369.2M. Across 12 filings, Holocene Advisors, LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,139,285 shares valued at US$284.0M — an increase of 2,401,186 shares quarter over quarter.. Notable position changes include a 286% increase in Q1 2024 (shares fell 3% over the following quarter), a 67% trim in Q1 2026 (shares rose 13% over the following quarter), a 325% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 625.08K $43.31M New
Q4 2023 880.95K $67.17M Add
Q1 2024 3.40M $324.78M Add
Q2 2024 2.86M $264.33M Reduce
Q3 2024 2.81M $185.26M Reduce
Q4 2024 2.41M $178.42M Reduce
Q1 2025 3.48M $252.27M Add
Q2 2025 4.70M $367.90M Add
Q3 2025 4.75M $369.15M Add
Q4 2025 2.25M $191.90M Reduce
Q1 2026 738.10K $59.11M Reduce
Q2 2026 3.14M $283.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Holocene Advisors, LP held EW?

Holocene Advisors, LP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Holocene Advisors, LP's current position in EW?

As of Q2 2026, Holocene Advisors, LP holds 3.14M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $283.98M, representing 0.67% of its reported portfolio and ranking #30.

Has Holocene Advisors, LP been buying or selling EW?

In the latest 13F filing (Q2 2026), Holocene Advisors, LP increased its position in EW. The position peaked in Q3 2025 at 4.75M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.